Bio-Rad Laboratories, Inc. (BIO)
NYSE: BIO · Real-Time Price · USD
280.08
-5.55 (-1.94%)
Feb 21, 2025, 4:00 PM EST - Market closed
Bio-Rad Laboratories Analyst Ratings
Total Analysts
4
Consensus Rating
Strong Buy
Price Target
$414.00
Upside
+47.81%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Reiterates $481 | Buy | Reiterates | $481 | +71.74% | Jan 14, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $369 → $481 | Buy | Maintains | $369 → $481 | +71.74% | Dec 9, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $400 → $450 | Strong Buy | Maintains | $400 → $450 | +60.67% | Oct 31, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $446 → $469 | Buy | Maintains | $446 → $469 | +67.45% | Oct 31, 2024 |
| Citigroup | Citigroup | Hold → Strong Buy Upgrades $350 → $400 | Hold → Strong Buy | Upgrades | $350 → $400 | +42.82% | Oct 1, 2024 |
| Wells Fargo | Wells Fargo | Hold Initiates $340 | Hold | Initiates | $340 | +21.39% | Aug 27, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $401 | Buy | Reiterates | $401 | +43.17% | Aug 16, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $402 → $401 | Buy | Maintains | $402 → $401 | +43.17% | Aug 2, 2024 |
| Citigroup | Citigroup | Hold Maintains $300 → $350 | Hold | Maintains | $300 → $350 | +24.96% | Aug 2, 2024 |
| UBS | UBS | Strong Buy Maintains $420 → $385 | Strong Buy | Maintains | $420 → $385 | +37.46% | May 8, 2024 |
| Citigroup | Citigroup | Strong Buy → Hold Downgrades $400 → $365 | Strong Buy → Hold | Downgrades | $400 → $365 | +30.32% | Apr 3, 2024 |
| UBS | UBS | Strong Buy Maintains $395 → $420 | Strong Buy | Maintains | $395 → $420 | +49.96% | Feb 16, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $484 → $480 | Buy | Maintains | $484 → $480 | +71.38% | Feb 16, 2024 |
| UBS | UBS | Strong Buy Initiates $395 | Strong Buy | Initiates | $395 | +41.03% | Dec 7, 2023 |
| Wells Fargo | Wells Fargo | Buy Maintains $550 → $525 | Buy | Maintains | $550 → $525 | +87.45% | Aug 7, 2023 |
| RBC Capital | RBC Capital | Buy Maintains $522 → $524 | Buy | Maintains | $522 → $524 | +87.09% | Aug 4, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.